|
End-of-day quote
Taiwan S.E.
06/11/2026
|
5-day change | 1st Jan Change | ||
| 1,270.00 TWD | +7.17% |
|
+6.72% | +199.74% |
Company Valuation: PharmaEssentia Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 78,065 | 143,840 | 114,578 | 204,725 | 173,829 | 526,328 | - | - |
| Change | - | 84.26% | -20.34% | 78.68% | -15.09% | 202.79% | - | - |
| Enterprise Value (EV) 1 | 75,148 | 133,629 | 94,995 | 183,725 | 153,423 | 503,280 | 492,086 | 526,328 |
| Change | - | 77.82% | -28.91% | 93.4% | -16.49% | 228.03% | -2.22% | 6.96% |
| P/E | -27.1x | -98.6x | -179x | 69.3x | 34.6x | 48.2x | 29.8x | 19.1x |
| PBR | 19.1x | 11.2x | 4.79x | 7.45x | 5.46x | 12.1x | 9.34x | - |
| PEG | - | 1.8x | 3x | -0x | 0.5x | 0x | 0.5x | 0.3x |
| Capitalization / Revenue | 119x | 49.9x | 22.4x | 21x | 11.1x | 19.4x | 12.7x | 7.89x |
| EV / Revenue | 114x | 46.4x | 18.6x | 18.9x | 9.81x | 18.6x | 11.9x | 7.89x |
| EV / EBITDA | -29x | -74.2x | -57.8x | 87.3x | 28.8x | 37.9x | 21.3x | 15.6x |
| EV / EBIT | -26.6x | -65.9x | -49.6x | 106x | 31.1x | 40.1x | 22.1x | 15.8x |
| EV / FCF | -29.7x | -73.5x | -49.8x | 102x | 41.7x | 48.7x | 44.9x | 15.6x |
| FCF Yield | -3.37% | -1.36% | -2.01% | 0.98% | 2.4% | 2.05% | 2.23% | 6.39% |
| Dividend per Share 2 | - | - | - | 0.8936 | 1.352 | 4 | 2.35 | 6 |
| Rate of return | - | - | - | 0.18% | 0.32% | 0.31% | 0.19% | 0.47% |
| EPS 2 | -8.773 | -3.932 | -1.568 | 7.214 | 12.25 | 26.35 | 42.57 | 66.4 |
| Distribution rate | - | - | - | 12.4% | 11% | 15.2% | 5.52% | 9.04% |
| Net sales 1 | 656.5 | 2,882 | 5,106 | 9,735 | 15,635 | 27,072 | 41,504 | 66,730 |
| EBITDA 1 | -2,595 | -1,800 | -1,645 | 2,104 | 5,327 | 13,267 | 23,103 | 33,770 |
| EBIT 1 | -2,822 | -2,028 | -1,913 | 1,736 | 4,928 | 12,563 | 22,252 | 33,246 |
| Net income 1 | -2,811 | -1,375 | -623.8 | 2,966 | 5,045 | 10,523 | 17,963 | 28,045 |
| Net Debt 1 | -2,917 | -10,211 | -19,582 | -21,000 | -20,406 | -23,048 | -34,242 | - |
| Reference price 2 | 238.02 | 387.49 | 281.07 | 499.59 | 423.70 | 1,270.00 | 1,270.00 | 1,270.00 |
| Nbr of stocks (in thousands) | 327,980 | 371,210 | 407,644 | 409,783 | 410,264 | 414,432 | - | - |
| Announcement Date | 2/3/22 | 1/3/23 | 27/2/24 | 26/2/25 | 3/3/26 | - | - | - |
1TWD in Million2TWD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 48.19x | 18.59x | 37.94x | 0.32% | 16.05B | |
| 17.43x | 6.68x | 12.81x | 1.71% | 66.7B | |
| 30.07x | 8.27x | 26.77x | 0.07% | 56.88B | |
| 38.45x | 6.84x | 20.45x | 0.85% | 56.53B | |
| 48.64x | 6.27x | 34.36x | -.--% | 46.49B | |
| 35.48x | 3.35x | 14.48x | -.--% | 44.8B | |
| -22.45x | 63.4x | -21.48x | -.--% | 41.59B | |
| 35.87x | 8.84x | 23.03x | 0.37% | 35.35B | |
| 42.3x | 8.09x | 26.47x | -.--% | 33.29B | |
| -69.1x | 13.21x | -71.01x | -.--% | 25.1B | |
| Average | 20.49x | 14.35x | 10.38x | 0.33% | 42.28B | |
| Weighted average by Cap. | 22.89x | 13.23x | 12.79x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 6446 Stock
- Valuation PharmaEssentia Corporation
Select your edition
All financial news and data tailored to specific country editions
